The administration of CA170 helps in boosting the infiltration of CD8+ T cells, decreasing the infiltration of MDSCs and Tregs, and exerting its potent anti-tumor effect, especially combined with the KRAS vaccine [85]. Here, CD8A is linked to neoplasm.